Purchase Order 75N93020P00146
- Not listed
- This is a $40,500 firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Polyorg, Inc., a for-profit manufacturer located in Leominster, MA. The order is for specialized chemical reagents including Fmoc-PNA monomers and Bhoc Nucleobase Acids, which are essential starting materials for NIDDK's research on thyclotides - molecules with potential diagnostic applications. The purchase order was awarded on a sole-source basis under...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Chembridge Corp, a small business, for a chemical compound library of 50,000 compounds at 0.25 micromoles each, for a total potential value of $44,000.00. The contract was awarded under Simplified Acquisition Procedures as a total small business set-aside. The chemical compounds are being acquired for use by the...
- This is a $11,242.78 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency under the Department of Health and Human Services (HHS). The contract is for the supply of chemicals required for experiments to support the agency's research programs, covering the end of the current fiscal year and start of the new fiscal year. The prime contractor is Sigma-Aldrich, Inc., a foreign-owned, for-profit organization that is...
- This federal contract award, valued at $50,000.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to the prime contractor Entrechem SL. The contract is for the purchase of 100 grams each of two specific enantiomers of trans-N-Boc-1,2-tetrahydro-3,4-furandiamine. These chemical compounds are needed as starting materials for the NIDDK's research into developing thyclotides, which...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Purchase Order contract to Asischem Inc. to provide custom synthesis of a chemical compound. The contract, valued at $4,890.00, was awarded on August 3, 2015 with a completion date of December 1, 2015. This contract was not set aside for any specific business type or size. Based on the agency name, this contract is likely related to NIAID's research and development programs focused on infectious...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order contract for $14,887.50 to Parse Biosciences, Inc., a for-profit manufacturer of biotechnology products and services. The contract, which does not have a set-aside designation, is for the delivery of reagents to support single-cell RNA and T-cell receptor (TCR) sequencing of secondary hemophagocytic...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services (HHS). The $145,621.08 firm-fixed-price purchase order was awarded to Global Life Sciences Solutions USA LLC, a for-profit limited liability company that manufactures and supplies biological products, equipment, and services to government agencies. The contract is for the delivery of "CONSUMABLE...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Sri International, a large non-profit research and development institute. The $75,537.00 contract is for the synthesis of 50 grams each of two non-GMP phenothiazinium compounds, which likely supports preclinical research efforts. The award is issued under NIAID's Nonclinical Services for Development of...
- This federal contract award, identified as HHSN272201501390P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The $6,130.60 firm-fixed-price purchase order was awarded to Invivogen, a for-profit organization, on September 23, 2015 for the product "AMBIS 1755049 ODN1826, 5MG; PRODUCT ID TLRL-1826-5." The contract did not have a set-aside designation and is scheduled for completion on...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to A & A Labs LLC, doing business as Synthetic Biomolecules. The $8,482.00 contract is for the custom synthesis of 15-mer peptides. The contract is set aside for small businesses and the awardee is a minority-owned, self-certified small disadvantaged business. The place of performance is San Diego,...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the synthesis of 100 grams of 6-diazo-5-oxo-L-norleucine (DON), a chemical compound, to be used in studying its potential as a vaccine additive for cerebral malaria. The contract was awarded to Peptide Solutions LLC, a for-profit limited liability company, for $26,730.00. The contract has no set-aside designation and was competed on an unrestricted full and open basis. The purchase order was issued under Simplified Acquisition Procedures in response to a solicitation posted on December 3, 2019, with an award date of December 17, 2019.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
DON (6-DIAZO-5-OXO-L-NORLEUCINE) IS A GLUTAMINE ANTAGONIST | RFQ-NIAID-1996193 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Solicitation 1/1 | 12/3/19, 5:28 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.7k | 12/17/19 |